Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common (2017 - 2018)

Teva Pharmaceutical Industries (TEVA) recorded quarterly Dividends Paid - Common of -$2.0 million in Q4 2018, down 200.0% on a QoQ basis from $2.0 million in Q3 2018.

Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common (2017 - 2018) Analysis & Trends

Teva Pharmaceutical Industries has disclosed Dividends Paid - Common across 2 years of filings, most recently posting -$2.0 million for Q4 2018.

  • Quarterly Dividends Paid - Common changed N/A year-over-year to -$2.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $10.0 million (down 73.68% YoY) and the FY2019 annual result came in at $52.0 million, up 420.0% from the prior year.
  • Dividends Paid - Common fell to -$2.0 million in Q4 2018, from $2.0 million in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $346.0 million in Q1 2017 and troughed at -$653.0 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Paid (Common) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 224.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 -2.00 Mn
Dec 31, 2018 -2.00 Mn
Sep 30, 2018 2.00 Mn
Sep 30, 2018 2.00 Mn
Jun 30, 2018 -2.00 Mn
Jun 30, 2018 -2.00 Mn
Mar 31, 2018 12.00 Mn
Mar 31, 2018 12.00 Mn
Sep 30, 2017 -653.00 Mn
Sep 30, 2017 -653.00 Mn
Jun 30, 2017 345.00 Mn
Jun 30, 2017 345.00 Mn
Mar 31, 2017 346.00 Mn
Mar 31, 2017 346.00 Mn